Streetbeat News

Earnings

RCKY

Rocky Brands (NASDAQ:RCKY) is anticipated to release its quarterly earnings report on 2024-02-28, with analysts estimating an EPS of $0.98. Historical data shows significant share price movements post-earnings announcements, with a notable 43.73% increase after last quarter's earnings beat. Shares are currently trading at $30.76, reflecting a 14.32% increase over the last 52 weeks. Investors are keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:01 pm

CCL

NCLH

Carnival Corporation (NYSE:CCL) shares are trading higher, likely in response to Norwegian Cruise Line Holdings, Ltd. (NYSE:NCLH) reporting mixed Q4 results but providing an upbeat 2024 outlook due to exceptional demand. This follows a similar positive guidance update from Royal Caribbean Group last week. Carnival's stock surge is also noted with trading volume surpassing its 100-day average. Additionally, the article discusses the challenges of forecasting long-term stock prices, using Carnival as an example to illustrate potential future stock performance based on past trends.

Portfolio Pulse from Erica Kollmann

February 27, 2024 | 8:01 pm

ALEX

Alexander & Baldwin (NYSE:ALEX) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.27. Despite past earnings misses, the stock price increased after the last report. Over the last year, ALEX shares have declined by 8.81%, trading at $17.01 as of February 26. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:01 pm

ICD

Independence Contract (NYSE:ICD) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.28. Analysts and investors will be closely watching for any positive guidance for the next quarter, especially considering the company's mixed historical earnings performance and the significant 53.23% decline in its share price over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:01 pm

CLMB

Climb Global Solutions (NASDAQ:CLMB) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.68. Historical data shows mixed reactions to past earnings, with a notable 2.8% drop after a miss last quarter. Shares have risen 51.81% over the past year, indicating positive sentiment among long-term investors.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:01 pm

VST

Vistra (NYSE:VST) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.26. Analysts and investors are keen on whether Vistra will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed earnings performance, with a notable miss last quarter leading to a slight share price drop. Vistra's stock has seen a significant increase of 131.64% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:01 pm

DAKT

Daktronics (NASDAQ:DAKT) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.17. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Daktronics's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. The company's shares have seen a significant increase of 102.83% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 8:00 pm

PRGO

Perrigo Company plc (NYSE:PRGO) reported mixed Q4 earnings with a slight miss on net sales at $1.16 billion versus the consensus of $1.18 billion but beat EPS estimates with $0.86, up 14.7% Y/Y. The company announced Project Energize, a cost-saving plan expected to yield $140-$170 million in annual pre-tax savings by 2026, despite projecting a net reduction of 6% of its workforce. Perrigo forecasts FY 2024 organic net sales growth of 1.0%-3.0% and adjusted EPS of $2.50-$2.65, below the consensus of $3.00. PRGO shares dropped 15.3% to $27.25.

Portfolio Pulse from Vandana Singh

February 27, 2024 | 7:46 pm

TMDX

TransMedics Group Inc (NASDAQ:TMDX) reported a Q4 profit with revenue of $81.2 million, up 159% Y/Y, surpassing the consensus of $68.51 million. The growth was attributed to increased use of its Organ Care System (OCS) and new logistics services. EPS was $0.12, beating the expected loss of $(0.03). The company expects FY 2024 revenues of $360-$370 million, above the consensus of $330.23 million. Oppenheimer raised TMDX's price target from $92 to $105 with an Outperform rating, and William Blair maintains an Outperform rating, highlighting the company's strong Q4 results and promising outlook.

Portfolio Pulse from Vandana Singh

February 27, 2024 | 7:33 pm

HIMS

JANX

NERV

NRXP

SJM

TWKS

VKTX

U.S. stocks showed mixed performance with the Dow Jones falling by 0.35% and the NASDAQ rising by 0.28%. J.M. Smucker reported better-than-expected earnings, while Janux Therapeutics, Hims & Hers Health, and Viking Therapeutics saw significant stock price increases. Conversely, Minerva Neurosciences, Thoughtworks Holding, and NRx Pharmaceuticals experienced notable declines. Oil and gold prices saw slight increases.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 7:32 pm